Tharlow: I've read brokers reports written by industry experts; have spoken with contacts in big-pharma and oncologists.
All tell me that there is NO TRFEATMENT for post-resection liver cancer AND there's nothing in mid- or late-stage trials. Given that drug development takes a min of 5-years, can you please help me out......what is the competition that you kerep referring to?
What do you know that the instudry guys do not?
